-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly Goodwill history and growth rate from Q4 2021 to Q1 2022.
- InMed Pharmaceuticals Inc. Goodwill for the quarter ending March 31, 2022 was $2.02M.